Cocrystal Pharma
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -33 | -35 | ||
EBITDA | -3,129 | -4,943 | -5,415 | -4,123 |
EBIT | -3,230 | -5,042 | -5,448 | -4,158 |
Net Income | -3,266 | -4,939 | -5,343 | -3,956 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,160 | -5,123 | -3,699 | -4,511 |
Cash | 9,860 | 13,020 | 18,143 | 21,917 |
Basic Shares | 10,174 | 10,174 | 10,174 | 10,174 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $5,427 |
Gross Profit | -15,169 | -241 | -239 | |
EBITDA | -17,878 | -19,372 | -38,447 | -13,799 |
EBIT | -17,984 | -38,835 | -14,181 | |
Net Income | -17,504 | -17,984 | -38,845 | -14,189 |
Net Change In Cash | 0 | 0 | 0 | 5,427 |
Free Cash Flow | -16,493 | -14,784 | -21,509 | -12,771 |
Cash | 9,860 | 26,353 | 37,144 | 58,705 |
Basic Shares | 10,174 | 9,651 | 8,143 | 88,368 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$0.32 |
2024-12-31 | -$0.32 |
2024-09-30 | -$0.49 |
2024-06-30 | -$0.53 |
